COG-ANBL2131: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
- Title
- A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
- Principal Investigator
- Meyer, Ashley
- Phase
- III
- Age Group
- Both
- Applicable Disease Sites
- Brain Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- West Virginia University
- Contacts
- Carla Corbin, RN, BSN
- Nurse Clinician
- Phone: +1 304-293-1217
- Email: ccorbin@hsc.wvu.edu